Literature DB >> 2142723

Autoantibodies specific for different isoforms of CD45 in systemic lupus erythematosus.

T Mimura1, P Fernsten, W Jarjour, J B Winfield.   

Abstract

Nearly one-third of IgM antilymphocyte autoantibody-positive sera from patients with systemic lupus erythematosus (SLE) contain IgM antibodies to one or more 180-220-kD molecules (p180, p190, p205, and p220) in blots of glycoproteins purified from T cells by wheat germ agglutinin affinity chromatography. Identity of these IgM targets with multiple isoforms of CD45 was established by their specific depletion from T cell glycoproteins by immunoprecipitation with T191, a monoclonal antibody (mAb) that reacts with an epitope common to all CD45 isoforms. Although the anti-CD45 autoantibodies recognize higher molecular weight isoforms primarily, antigenic specificity in this system is quite heterogeneous and includes multiple distinct CD45 isoforms on different types of T cells that are, at least in part, different from those reactive with mAbs 2H4 and UCHL-1. Because CD45 is a major membrane protein tyrosine phosphatase that plays a critical role in antigen-induced T cell activation, the present data may be relevant to some of the antilymphocyte antibody-mediated immunologic abnormalities that characterize SLE and related autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142723      PMCID: PMC2188347          DOI: 10.1084/jem.172.2.653

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

Review 1.  Leukocyte cell surface enzymology: CD45 (LCA, T200) is a protein tyrosine phosphatase.

Authors:  E A Clark; J A Ledbetter
Journal:  Immunol Today       Date:  1989-07

2.  Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression.

Authors:  J A Ledbetter; L M Rose; C E Spooner; P G Beatty; P J Martin; E A Clark
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

3.  Antilymphocyte antibodies and systemic lupus erythematosus.

Authors:  C Morimoto; S F Schlossman
Journal:  Arthritis Rheum       Date:  1987-02

4.  Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activity.

Authors:  C J Rosenthal; E C Franklin
Journal:  Arthritis Rheum       Date:  1975 May-Jun

5.  Subset specificity of antilymphocyte antibodies in systemic lupus erythematosus. Preferential reactivity with cells bearing the T4 and autologous erythrocyte receptor phenotypes.

Authors:  A Yamada; P L Cohen; J B Winfield
Journal:  Arthritis Rheum       Date:  1985-03

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody.

Authors:  C Morimoto; A D Steinberg; N L Letvin; M Hagan; T Takeuchi; J Daley; H Levine; S F Schlossman
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

8.  Subset specificity of antilymhocyte antibodies in systemic lupus erythematosus. II. Preferential reactivity with T4 + cells is associated with relative depletion of autologous T4 + cells.

Authors:  J B Winfield; M Shaw; A Yamada; S Minota
Journal:  Arthritis Rheum       Date:  1987-02

9.  Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.

Authors:  A Yamada; J B Winfield
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.

Authors:  C Morimoto; D A Hafler; H L Weiner; N L Letvin; M Hagan; J Daley; S F Schlossman
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

View more
  10 in total

1.  Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.

Authors:  M T Kasaian; H Ikematsu; P Casali
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

Review 2.  Anti-lymphocyte autoantibodies in systemic lupus erythematosus.

Authors:  J B Winfield; P D Fernsten; J K Czyzyk
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

Review 3.  Role of Natural IgM and IgM Induced Bregs in Preventing Ischemia Induced Innate Inflammation and Acute Kidney Injury.

Authors:  Peter I Lobo; Mark D Okusa
Journal:  Nephron       Date:  2019-07-09       Impact factor: 2.847

Review 4.  Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus.

Authors:  J B Winfield; P Fernsten; J Czyzyk; E Wang; J Marchalonis
Journal:  Springer Semin Immunopathol       Date:  1994

5.  Autoantibodies against CD28 are associated with atopic diseases.

Authors:  K Neuber; B Mähnss; C Hübner; H Gergely; M Weichenthal
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

6.  B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation.

Authors:  P E Spronk; B T vd Gun; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

7.  Presence of T-cell subset abnormalities in newly diagnosed cases of multiple sclerosis and relationship with short-term clinical activity.

Authors:  M Eoli; M Ferrarini; A Dufour; S Heltaj; L Bevilacqua; G Comi; V Cosi; G Filippini; V Martinelli; C Milanese
Journal:  J Neurol       Date:  1993-02       Impact factor: 4.849

8.  Carbohydrate specificity of IgM autoantibodies to CD45 in systemic lupus erythematosus.

Authors:  P D Fernsten; J K Czyzyk; T Mimura; J B Winfield
Journal:  Mol Biol Rep       Date:  1994       Impact factor: 2.316

9.  Immunosuppressive human anti-lymphocyte autoantibodies specific for the type 1 sphingosine 1-phosphate receptor.

Authors:  Jia-Jun Liao; Mei-Chuan Huang; Katharine Fast; Katherine Gundling; Mahesh Yadav; James R Van Brocklyn; Matthias R Wabl; Edward J Goetzl
Journal:  FASEB J       Date:  2009-01-21       Impact factor: 5.191

10.  Autoantibodies against CD80 in patients with COPD.

Authors:  Xu Min Luo; Xin Yan Liu; Ji Hong Tang; Wei Yang; Zhen Hua Ni; Qing Ge Chen; Xiongbiao Wang
Journal:  Clin Transl Immunology       Date:  2016-10-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.